Eisai is a Japan-based global research-driven pharmaceutical company focused on the discovery, development, manufacturing, and commercialization of prescription and over-the-counter medicines. The company's key therapeutic areas include neurology (notably Alzheimer's disease with its anti-amyloid antibody Leqembi/lecanemab) and oncology (including Lenvima/lenvatinib and tazemetostat). Operating under its 'human health care' (hhc) philosophy, Eisai also actively engages in access-to-medicine initiatives in developing countries, including the supply of lymphatic filariasis treatments across 33 nations.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →Eisai is a Japan-based global research-driven pharmaceutical company focused on the discovery, development, manufacturing, and commercialization of prescription and over-the-counter medicines. The company's key therapeutic areas include neurology (notably Alzheimer's disease with its anti-amyloid antibody Leqembi/lecanemab) and oncology (including Lenvima/lenvatinib and tazemetostat). Operating under its 'human health care' (hhc) philosophy, Eisai also actively engages in access-to-medicine initiatives in developing countries, including the supply of lymphatic filariasis treatments across 33 nations.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →